Table 3.

Cardiac Magnetic Resonance Results Before and After 2 Vaccination Doses (n = 67)

	Before 1st vaccine dose	After 2nd vaccine dose	p-value
LV EDV Indexed (ml/m2)	81 $\pm$ 12	81 $\pm$ 12	0.798
LV ESV Indexed (ml/m2)	35 $\pm$ 7.0	35 $\pm$ 8.2	0.854
LV EF (%)	58 $\pm$ 5.0	57 $\pm$ 5.3	0.088
LV Mass Indexed (g/m2)	46 $\pm$ 8.4	45 $\pm$ 8.6	0.094
Cardiac Index (L/min/m2)	3.3 $\pm$ 0.50	3.2 $\pm$ 0.6	0.431
Global Longitudinal Strain (%)	17 $\pm$ 2.0	17 $\pm$1.8	0.881
RV EDV Indexed (ml/m2)	87 $\pm$ 18	87 $\pm$ 15	0.987
RV ESV Indexed (ml/m2)	40 $\pm$9.2	41 $\pm$ 9.7	0.627
RV EF (%)	54 $\pm$ 5.5	54 $\pm$ 5.7	0.412
LA Area Corrected (cm2/m2)	13 $\pm$ 1.8	12 $\pm$ 1.8	0.088
RA Area Corrected (cm2/m2)	12 $\pm$ 2.2	12 $\pm$ 2.6	0.329
Pericardial Effusion (n, %)	1 (1.5%)	1 (1.5%)	1.00
Global Native T1 Myocardium (msec)	1045$\pm$50	1055 $\pm$ 55	0.303
Global Native T2 Myocardium (msec)	49.5 $\pm$ 4.2	50.5 $\pm$ 4.4	0.191
ECV Myocardium (%)	27.9 $\pm$ 3.8	27.8 $\pm$ 4.4	0.901
LGE Present	1 (1.5%)	1 (1.5%)	1.00
T2 STIR Abnormalities	0	0	1.00
Lake Louise Criteria Fulfilled (%)	0%	0%	1.00

Results are presented as mean and standard deviation

LV left ventricle, EDV corrected end diastolic volume, ESV corrected end systolic volume, EF ejection fraction, RV right ventricle, ECV extracellular volume, LGE late gadolinium enhancement, STIR short tau inversion recovery